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Abstract.  We describe the isolation of a set of over- 
lapping cDNAs encoding mouse microtubule associ- 
ated protein 2 (MAP2), using an anti-MAP antiserum 
to screen a mouse brain cDNA expression library 
cloned in bacteriophage hgt 11. The authenticity of 
these clones was established by the following criteria: 
(a) three non-identical clones each expressing a 
MAP2 immunoreactive fusion protein were independ- 
ently isolated from the expression library; each of 
these clones cross-hybridized at the nucleic acid level; 
(b) anti-MAP antiserum was affinity purified using 
nitrocellulose-bound fusion protein; these antibodies 
detected only MAP2 in an immunoblot experiment of 
whole brain microtubule protein; (c) a series of cDNA 
"walking" experiments was done so as to obtain a 
non-overlapping cloned fragment corresponding to a 
different part of the same mRNA molecule. Upon 
subcloning this non-overlapping fragment into plas- 
mid expression vectors, a fusion protein was synthe- 
sized that was immunoreactive with an anti-MAP2 
specific antiserum. Thus, a single contiguous cloned 
mRNA molecule encodes at least two MAP2-specific 
epitopes; (d) the cloned cDNA probes detect an 
mRNA species in mouse brain that is of a size (-9 kb) 
consistent with the coding capacity required by a 
250,000-D protein. 
The MAP2-specific cloned cDNA probes were used 
in RNA blot transfer experiments to assay for the 
presence of MAP2 mRNA in a variety of mouse tis- 
sues. Though brain contained abundant quantities of 
MAP2 mRNA, no corresponding sequences were de- 
tectable in RNA prepared from liver, kidney, spleen, 
stomach, or thymus. We conclude that the expression 
of MAP2 is brain-specific. 
Use of the MAP2 specific cDNA probes in genomic 
Southern blot transfer experiments showed the pres- 
ence of a single gene encoding MAP2 in mouse. The 
microheterogeneity of MAP2 is therefore ascribable 
either to alternative splicing within a single gene, or to 
posttranslational modification(s), or both. Under con- 
ditions of low stringency, the mouse MAP2 cDNA 
probe cross-hybridizes with genomic sequences from 
rat, human, and (weakly) chicken, but not with se- 
quences in frog, Drosophila, or sea urchin DNA. 
Thus, there is significant interspecies divergence of 
MAP2 sequences. The implications of the above ob- 
servations are discussed in relationship to the poten- 
tial biological function of MAP2. 
T 
EMPERATURE-DEPENDENT polymerization  of micro- 
tubules in  vitro  results in the co-assembly,  together 
with a- and #-tubulin,  of a group of proteins  known 
collectively as the microtubule associated proteins (MAPs). 
These proteins promote the microtubule assembly process in 
vitro (8,  18,  19, 24, 25, 32) and at least some of them have 
been localized as projections  from the surface of the micro- 
tubule polymer (1, 11, 14). Thus, while the precise biological 
function  of MAP remains  to be clearly demonstrated,  they 
could potentially mediate the interaction ofmicrotubules with 
other cellular  elements  as well as serve  in  the  control  of 
microtubule polymerization. 
Two major groups of MAP have been defined on the basis 
1.  Abbreviations usedin this paper." MAP, microtubule associated protein; SSC, 
150 mM NaC1, 15 mM Na citrate; TBST, 50 mM Tris-HC1, pH 7.5, 150 mM 
NaCI, 0.05% Tween 20. 
of molecular weight: the high molecular weight MAP (in the 
range 240,000-350,000  D) and the low molecular weight tau 
proteins  (55,000-62,000  D) (8). The high molecular  weight 
group  contains  two  members,  MAP1 (>300,000  D)  and 
MAP2 (250,000-300,000  D) (24), that are biochemically and 
immunologically distinct. Each group exhibits heterogeneity 
on one-dimensional  SDS polyacrylamide gels: in the case of 
MAP1,  three  discrete  but closely migrating  bands,  named 
MAPIa, lb, and lc, have been identified, whereas MAP2 can 
be resolved into two components termed MAP2a and 2b (30). 
The molecular basis for the heterogeneity of the high mo- 
lecular weight MAP is unclear. While protein chemical char- 
acterization  (for  example,  analysis  of proteolytic  digestion 
products) has been useful in showing the relatedness of some 
MAP (e.g., MAP2a and 2b [ 10, 21 ]), such experiments cannot 
distinguish between the expression of two similar but non- 
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single protein that could then undergo posttranslational mod- 
ification(s). To investigate the heterogeneity of the high mo- 
lecular  weight  MAPs  at  the  genetic  level,  we  decided  to 
construct MAP-specific cDNA clones that could be used as 
probes to  assay the  number of genes encoding each  MAP 
group. Such clones will also serve as a basis for understanding 
the  structure,  expression,  evolution,  and  function  of these 
proteins. Here we report the isolation of cDNA clones encod- 
ing mouse MAP2. These clones have been used to show the 
existence of a  single mouse gene encoding the MAP2  poly- 
peptide, with expression restricted exclusively to brain tissue. 
Materials and Methods 
Construction and Screening of  a Mouse Brain 
cDNA Library 
Mouse brain polyA  ÷ mRNA was prepared from 8-d-old mice by the guanidine 
isothiocyanate procedure (3).  Double-stranded eDNA was synthesized from 
this material and inserted into the bacteriophage Xgtl I vector (35) as described 
(16). Approximately 5 x  105 recombinant plaques were screened using a rabbit 
anti-rat MAP antiserum (23) at a dilution of 1:500. Clones giving a positive 
signal  with the avidin/biotin/peroxidase complex procedure (Vector Labora- 
tories,  Burlingame, CA) were picked, purified to homogeneity, and the eDNA 
inserts subcloned into plasmid pUC8 for further amplification and study. 
Identification of Overlapping Clones by 
cDNA "Walking" 
Excised  inserts from clones that express immunoreactive fusion proteins, or 
restriction fragments derived from such clones, were 32P-labeled by nick trans- 
lation and used to screen the cDNA library (2) for cross-hybridizing  sequences. 
After hybridization, the filters  were  washed to a final stringency of 2  x  SSC 
(150 mM NaC1, 15 mM Na citrate),  68"C. Clones giving positive signals were 
picked as 5-mm plugs using the open end of a Pasteur pipet, and the bacterio- 
phage eluted in 1 ml of  0.1 M NaCI,  10 mM Tris-Hcl, pH 8.0,  10 mM MgSO4. 
An aliquot (30 #1) of the eluted bacteriophage was amplified in a small (1 ml) 
culture without further purification, and DNA prepared from each lysate by 
the method described (17). The final product was dissolved in 40 t~l of 10 mM 
Tris-HCl, pH 7.5,  1 mM EDTA, and 20 #1 of this solution digested with EcoRI 
under the conditions specified by the suppher (New England Biolabs, Beverly, 
MA). The digestion products were resolved on a 1% agarose gel, the gel content 
transferred to nitrocellulose (27), and the blot hybridized with ~ 107 cpm of the 
same probe(s)  used to screen the cDNA library (see above).  After washing to 2 
× SSC, 68"C, the blots were exposed to film. This procedure served to identify 
those plugs that contained bacteriophage with large  recombinant inserts ho- 
mologous  to the probes used to screen the library. Eluates from plugs identified 
in  this manner were  subjected to  two  rounds of plaque  purification; the 
recombinant insert from a single isolated plaque giving a positive hybridization 
signal with the labeled probe was then subeloned into pUC8 and amplified for 
further study by restriction mapping and analysis in RNA blot transfer experi- 
merits. 
Production of  Anti-Mouse MAP1 and MAP2 Antisera 
and Immunoblotting 
Two-cycle  purified microtubules were prepared from the brains of adult mice 
(22).  For the preparation  of MAPI,  the high molecular weight MAP were 
resolved on preparative SDS gels as described (34),  the MAPI  polypeptides 
excised and used directly as immunogens  in rabbits (9). For the preparation of 
MAP2, a heat stable fraction that contained primarily MAP2 was prepared as 
described (11), further purified on an SDS polyacrylamide  gel, and used directly 
as immunogen (9). Sera were tested for their specificity  on immunoblots (28) 
prepared  from one-cycle mouse brain microtubules: immunoreactive bands 
were detected with the avidin/biotin/peroxidase reagents used according to the 
procedures recommended by the supplier (Vector Laboratories). 
Preparation of  Sera Purified by Affinity to a Fusion 
Protein Expressed in Bacteriophage Xgt11 
Approximately 6  x  I(P  bacteriophage  of either  wild-type  hgtl I  or  ),gtl 1 
expressing  clone 56 (see Fig. 4) were plated out and induced for 2 h at 37"C by 
ovedaying with a  nitrocellulose filter  saturated with  10 mM isopropyl fl-~ 
thiogalactopyranoside (35).  The filters were removed, rinsed in 50 mM Tris- 
HCI, pH 7.5,  150 mM NaCl, 0.05% Tween 20 (TBST), and blocked for 30 rain 
at room temperature in TBST that contained 3% bovine serum albumin (BSA). 
Each filter  was then immersed for 1 h in 0.1  ml of affinity purified anti-rat 
MAP antibody (23) diluted 1:100 in TBST that contained 3% BSA. ARer three 
5-rain rinses in TBST, the bound antibody was eluted for  15 rain at room 
temperature with 3 ml of 100 mM glycine-HCl, pH 2.6, 150 mM NaCI. The 
nitrocellulose  was removed, the solution adjusted to pH 7.5 with I M Tris, and 
stabilized by the addition of 2 ml of TBST that contained 3% BSA. 
RNA Preparation and DNA and RNA Blot 
Transfer Experiments 
RNA for blot transfer analysis on 0.8%  gels that contained formaldehyde (6) 
was prepared by the guanidine isothiocyanate procedure (3). Genomic DNAs 
from  mouse,  rat,  human, chicken,  frog,  Drosophila, and  sea urchin were 
digested with restriction enzymes under the conditions specified by the manu- 
facturer (New England Biolabs).  Restriction digests of DNA were resolved on 
0.8% agarose gels and transferred to nitrocellulose as described (27). 
Results 
Isolation of  Clones from a cDNA Expression Library 
Using a MAP-specific Antiserum 
To  isolate  cDNA  clones encoding MAP,  we  constructed a 
cDNA expression libary in ;kgtl 1 using polyA  + mRNA from 
the brains  of 8-d-old  mice.  Approximately  5  x  105  clones 
were  screened for the expression of MAP  using an affinity- 
purified  polyclonal  rabbit  anti-rat  MAP-specific  antibody 
(23). Seven clones that yielded a positive signal with the anti- 
MAP  antiserum  were  obtained.  Each  positive  plaque  was 
Figure 1. Two noncross-hybridizing sets of overlapping cDNA clones 
expressing anti-MAP immunoreactive fusion proteins. Screening of a 
mouse brain  cDNA  expression library  resulted  in  the isolation  of 
seven  clones  each  yielding  a  positive  signal  with  a  MAP-specific 
antiserum. The recombinant inserts were excised, 32P-labeled by nick 
translation (20), and tested in a dot-blot experiment to determine the 
sequence relationships among them. In the figure, 52l and 52s refer 
to the large and small EcoRI fragments contained in a  single recom- 
binant (see Fig. 4). 
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infection, in each case expressing fusion proteins that repro- 
ducibly reacted  with  the  antibody.  After amplification  and 
subcloning into plasmid vectors, the recombinant inserts were 
isolated and tested for their ability to cross-hybridize with one 
another (Fig.  1). The data show that the seven clones fall into 
two distinct, non-cross-hybridizing classes. This result was not 
unexpected,  since  the  antibody  used  to  screen  the  cDNA 
expression  library  recognizes  both  MAP1  and  MAP2  (see 
below) and, in any event, the potential existed for recognizing 
more than one epitope on non-overlapping cloned fragments 
from the same mRNA. 
While the generation of positive signals by reaction of an 
antibody  with  fusion  proteins  expressed  in  Xgtl I  provides 
some indication of success, further experimental  evidence is 
required  to  establish  that  the  cloned  fragments  do  indeed 
encode the  desired  product.  This is  because  a  large  cDNA 
expression  library  cloned  without  regard  to  orientation  or 
frame  could  lead  to  the  synthesis  of fusion  proteins  that 
contained  epitopes  adventitiously  recognized  by  the  anti- 
serum  used to screen  the library (16).  In addition,  it is not 
inconceivable  that  the  antibody  might  recognize  a  cross- 
reacting  non-MAP protein  present  at  very low abundance, 
but  nonetheless  represented  in  the  cDNA library.  Conven- 
tionally, the authenticity of cloned cDNAs is established  by 
hybrid  selection  of mRNA  and  translation  of the  selected 
material  in  a  cell-free system (e.g.,  15,  16).  The translation 
product  can  then  be  characterized  either  biochemically  or 
immunochemically or both. However, attempts to character- 
ize our cDNA clones in this manner yielded multiple trans- 
lation products immunoprecipitable with the anti-MAP anti- 
serum, a result that we ascribe to the synthesis of an array of 
prematurely terminated  polypeptides in the cell-free system 
(data  not  shown).  Such  premature  termination  might  be 
expected to occur given the large size of MAP and the limi- 
tations  on  protein  synthesis  in  vitro.  We  therefore  did  the 
following kinds of experiment to characterize our clones. (a) 
Antibodies selected by their affinity for the immunoreactive 
fusion protein encoded by a cDNA clone were prepared and 
used to probe blots of total mouse brain microtubule protein, 
in  order to determine  with which  MAP (if any) the  fusion 
protein  shared  common epitopes.  (b)  Fusion proteins  were 
generated from non-overlapping regions of cDNA molecules 
cloned from a single mRNA species and tested for their ability 
to react independently with anti-MAP antisera.  Three anti- 
sera  were  used  for these  experiments:  the  affinity  purified 
anti-MAP antiserum used to screen the library (23), as well 
as an anti-mouse MAP1 antiserum and an anti-mouse MAP2 
antiserum raised especially for this purpose. The specificity of 
these  sera  was  determined  by  the  immunoblotting  experi- 
ments depicted in Fig. 2. 
Characterization of  the Antibody Selected by cDNA- 
encoded Fusion Proteins 
To determine the specificity of the antibodies that recognized 
the immunoreactive fusion proteins, an experiment was done 
Figure 2. Characterization  of MAPI- and  MAP2-specific antisera. 
The rabbit  anti-rat  MAP antibody (23)  used  to screen the  kgtl 1 
cDNA expression library and two additional  rabbit  antiscra  raised 
against purified mouse MAPI and mouse MAP2 were characterized 
in an immunoblotting experiment  using one-cycle purified  mouse 
brain  microtubules  resolved on a  5% SDS polyacrylamide gel that 
contained  25% glycerol (34). (A) Coomassie Blue stain; (B, C, and 
D) immunoblots stained and the anti-rat MAP antibody, anti-mouse 
MAPI antibody, and anti-mouse MAP2 antibody, respectively. 
Figure 3  A fusion protein immunoreactive  with an anti-MAP anti- 
body selectively binds antibodies that detect MAP2, but not MAPl. 
The fusion protein expressed by clone 56 (Figs. l and 4) was bound 
to a nitrocellulose filter and used to select antibodies from the anti- 
rat  MAP antiserum  used  to screen the  cDNA expression library. 
Antibodies binding to the filter were eluted and used in an immu- 
noblotting experiment with one-cycle purified mouse brain microtu- 
bule protein. (A) Negative control (filter-bound proteins from a non- 
recombinant  ~,gtl 1 clone); (B) positive control (using antibody re- 
maining after filter selection); (C) antibody bound and eluted from a 
filter that contained the fusion protein expressed by clone 56 (see Fig. 
4). 
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Figure 4. Restriction maps of overlapping cDNA clones obtained by 
cDNA "walking" experiments. A series of"walking" experiments was 
done in which the cDNA clones expressing MAP2-specific immuno- 
reactive fusion proteins (marked E  in the figure) and a  number of 
successively overlapping clones were used to rescreen the hgt 11 cDNA 
library.  The  extent  of overlap (as  determined  by  the  location  of 
common restriction sites) is shown in the figure.  The transcriptional 
orientation,  as  determined  by  restriction  mapping  of the  original 
expression  clones in  hgtl I  with respect  to  the lac Z  promoter,  is 
indicated by the arrow. Vertical bars denote EcoRI sites.  The trans- 
lation termination  codon,  determined  from  the  size of the  fusion 
protein expressed by clone 59 (see text and Fig.  5), lies downstream 
from the internal EcoRI site common to clones 52,  59, and  113. <>, 
KpnI; ,, PstI; T, Sad; V, BglI; A, HindlII. 
in  which  the  fusion  proteins were  fixed  to a  nitrocellulose 
filter and allowed to react with the antiserum used to screen 
the cDNA expression library. Bound antibody was then eluted 
from the filter and its specificity determined in an immuno- 
blotting  experiment  using  total  mouse  brain  microtubule 
protein resolved in a  5%  SDS  polyacrylamide gel that con- 
tained 25%  glycerol (10).  The result (Fig.  3C)  showed that 
antibody selected by its affinity for the fusion protein from 
one of the two sets of cross-hybridizing clones (clones 33a, 
54, and 56, Fig.  1) exclusively recognized MAP2.  Thus, the 
fusion  proteins  within  this  group  contained  one  or  more 
epitopes in common with authentic MAP2. 
A Single Contiguous  Cloned cDNA Encodes at Least 
Two MAP2-specific Epitopes 
Because an epitope can span a  region as small as about five 
or  six  amino  acids,  a  single  MAP2-specific epitope  might 
conceivably be generated by the adventitious expression of a 
cDNA molecule resulting from the cloning of an  unrelated 
mRNA in the wrong orientation and/or reading frame (see, 
e.g.,  reference  16). On  the  other hand,  the probability of a 
single cDNA molecule encoding two or more adventitiously 
expressed MAP2-specific epitopes  is  vanishingly  small.  To 
obtain a series of cloned cDNAs spanning an extended region 
of a  single,  contiguous mRNA molecule, a  series of cDNA 
"walking" experiments was done in which the initial recom- 
binant  fragments isolated from the  expression library were 
used to rescreen the  library for overlapping molecules that 
served to further extend the cDNA. In each case, the authen- 
ticity of  the overlapping clones was determined by two criteria: 
(a) the isolation of multiple overlapping clones sharing com- 
mon restriction sites;  and  (b)  the  detection  of an identical 
mRNA species by each overlapping clone when  used  as a 
labeled probe in an RNA blot transfer experiment with total 
mouse brain RNA (see below). The results of these "walking" 
experiments yielded a series of overlapping cDNAs represent- 
ing a contiguous stretch of ~7 kb; the extent of each cloned 
cDNA and its restriction map are shown in Fig. 4. Inspection 
of the  figure shows that,  as a  result of "walking," a  cDNA 
clone (clone 59) was obtained that is non-overlapping with 
Figure 5. Two non-overlapping 
cDNAs encoding a contiguous 
mRNA  molecule  express 
MAP2-spccific  immunoreac- 
rive fusion proteins.  The large 
EcoRI fragment from clone 59 
(Fig. 4) which does not overlap 
clone 33a (one of the original 
expression clones in ~,gt  I l) was 
subcloned in both orientations 
and  all  three  reading  frames 
into inducible plasmid expres- 
sion vectors (see text). The re- 
suiting  fusion  proteins  were 
analyzed by staining with (A) 
Coomassie  Blue,  and  immu- 
noblotting with  (B)  the  anti- 
rat  MAP  antiserum  used  to 
screen the cDNA expression li- 
brary  (23)  and  (C)  the  anti- 
mouse  MAP2-specific  anti- 
body.  In each track  of A, the 
unique prominent band  is the 
trpE fusion protein. Each lane 
represents  a  different  reading 
frame for the cloned insert. 
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the cDNA expression library. The large EcoRI fragment from 
clone 59 was then inserted into inducible plasmid expression 
vectors (generously provided by T. J. Koerner, Duke Univer- 
sity,  NC) in all six reading frames, and the resulting fusion 
proteins  tested  for their  immunoreactivity with  either  the 
anti-rat-MAP antiserum (23) or the MAP2-specific antiserum 
described above (see Fig.  2). In one orientation and reading 
frame, the larger EcoRI fragment from clone 59 expressed a 
150,000-D fusion protein that was detected by our anti-MAP 
antiserum (Fig.  5) of which  37,000  D  are accounted for by 
the trpE-encoded portion. In addition, and as an added con- 
trol,  the  MAP 1-specific  antiserum  did  not  recognize  this 
fusion protein (see  accompanying paper, Fig.  3.11.3). Thus, 
two  non-overlapping fragments (33a  and  the  large EcoRI 
fragment of  59, Fig. 4) cloned from a single contiguous mRNA 
molecule both encode separate MAP2-specific epitopes. 
Size and Tissue-specific Expression of  MAP2 mRNA 
Though MAP2 is abundantly expressed in neuronal cells, the 
expression of this protein in non-neuronal tissue, determined 
in immunocytochemical studies using fluorescent polyclonal 
or monoclonal antisera (4, 7, 9,  12, 13, 29, 33, 34), is a matter 
of controversy. We therefore did RNA blot transfer experi- 
ments  using  our  MAP2-specific  cloned  probes  to  detect 
MAP2-specific mRNA in brain and a variety of other mouse 
tissues.  This experiment also served to establish the  size of 
MAP2-specific  mRNA.  The  data  (Fig.  6)  reveals  a  single 
molecular species of ~9  kb that  is present in brain,  but  is 
undetectable in other mouse tissues. 
A Single Gene Encodes MAP2 in Mouse 
In view of the existence of two resolvable MAP2 subcompo- 
nents  (MAP2a  and  MAP2b),  an  important  question  is 
whether these polypeptides are encoded by separate though 
related genes, or whether a single gene encodes one (or more) 
MAP2  polypeptide(s) which  can then  undergo  posttransla- 
tional  modification.  To determine the  number of genomic 
sequences homologous to our MAP2-specific cloned cDNA 
probes,  a  genomic  Southern  blot  transfer experiment was 
done. Because the mRNA encoding MAP2 is large (~9 kb, 
Fig.  6), we selected several probes for this experiment, three 
of which  lacked  recognition  sites  for  one  or  more  of the 
restriction enzymes used to digest the  genomic DNA.  The 
blots were hybridized and washed at relatively low stringency 
so as to allow the detection of related genes that might share 
Figure  6.  A  large (~9-kb) 
mRNA encoding MAP2 is ex- 
pressed exclusively in  mouse 
brain.  Aliquots (15  #g)  of 
polyA  ÷  RNA  prepared  from 
mouse tissues were resolved in 
an 0.8% agarose gel that con- 
rained 1.5 M formaldehyde (6) 
and the gel content transferred 
to nitrocellulose (27). The blot 
was prehybridized and hybrid- 
ized  with the  excised insert 
from clone 56 (Fig. 4) 32p-la- 
beled by nick-translation (20). 
Lanes 1-6,  RNA from brain, 
kidney, liver, spleen, stomach, 
and thymus,  respectively. (A) 
12-h exposure; (B) same blot 
as A exposed for 500 h. 
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As seen in Fig. 7, even at this stringency these three fragments 
(59 [large EcoRI fragment], 56, 59 [small EcoRI fragment]) 
detect only one BamH 1 fragment and one KpnI fragment (or 
two in the case of 56, which is cut once by KpnI). However, 
clone 47 detects four fragments in each digest. Because these 
signals remain even at very high stringency (70*(2, 0.2 x  SSC, 
data not shown), they most likely reflect the interruption of 
the  MAP2  gene  by large  introns  that  occur in  the  region 
encoded  by  clone  47,  rather  than  a  very  close  homology 
between a  different gene and this very small  portion of the 
MAP2 mRNA. 
Limited lnterspecies Conservation of the MAP2 Gene 
The existence  of MAP2  has  been  reported  in  cells  from  a 
number of  different species (26, 29, 3 I). However, apart from 
the ability of MAP2-specific antisera to detect MAP2 across 
species boundaries,  the  extent  of evolutionary conservation 
of the gene encoding MAP2 is unknown. To investigate this 
question,  a  Southern  blot  experiment  was  done  using  our 
labeled cloned cDNAs to probe digests ofgenomic DNA from 
rat, human, chicken, frog, sea urchin, and Drosophila. While 
Figure 8. The gene encoding mouse MAP2 cross-hybridizes with rat, 
human, and chicken DNA, but not with DNA from frog, Drosophila, 
or sea urchin. The two excised EcoRI fragments from clone 59 and 
the excised insert from clone 56 were 32P-labeled by nick-translation 
(20), mixed, and used to probe a Southern  blot (27) prepared  using 
Hindlll digests of 5 ug of genomic  DNA. After hybridization,  the 
blot was washed as described in Fig. 7. Lanes 1-7, DNA from mouse, 
rat, human, chicken, frog, sea urchin, and Drosophila. Size markers 
(in kb) are shown at the left. 
there is cross-hybridization at low stringency (2x SSC, 42"C) 
with DNA from rat, human, and (weakly) chicken DNA, no 
discrete bands were obtained with DNA from frog, sea urchin, 
or Drosophila (Fig. 8). The background hybridization detected 
at low stringency in frog DNA was not retained on washing 
to higher stringencies (data not shown). We conclude, there- 
fore, that there is limited interspecies conservation among the 
sequences encoding MAP2. 
Figure 7. A single copy gene encodes mouse MAP2. The two excised 
EcoRl fragments from clone 59, and the excised inserts from clones 
47 and 56 (Fig. 4) were each ~2p-labeled by nick-translation  (20) and 
used  to probe genomic  Southern  blots  (27) of restriction  digested 
mouse  DNA. After hybridization,  the blots were washed to a final 
stringency  of 2x  SSC, 42"C, so as  to allow the detection  of any 
homologous but mismatched  sequences (see text). Lanes 1, 3, 5, and 
7, BamHI; lanes 2, 4, 6, and 8, KpnI. The blots shown in A, B, C, 
and D  were probed with  labeled  inserts  from clones  47,  59 (large 
EcoRI fragment), 56, and 59 (small EcoRI fragment),  respectively. 
Size markers (in kb) are shown at left. 
Discussion 
This paper describes the isolation of a  series of overlapping 
cDNA clones encoding mouse MAP2.  The isolation proce- 
dure  depended  on  screening a  mouse  brain  eDNA  library 
cloned in bacteriophage ),gt I 1, using a polyclonal rabbit anti- 
rat  MAP  antiserum  (23)  that  recognizes  both  MAPI  and 
MAP2. While the independent isolation of two sets of cross- 
hybridizing cDNAs (Fig. l) each yielding an immunoreactive 
fusion protein was indicative of the successful identification 
of  MAP-specific clones, several further experiments were done 
to establish  their  authenticity.  First,  the  fusion protein  ex- 
pressed by the largest member of one set of clones selected 
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library  that  specifically recognized  MAP2.  Second,  eDNA 
"walking" experiments were done so as to generate a  non- 
overlapping  cloned  fragment  (with  respect  to  one  of the 
original clones) that expressed a fusion protein recognized by 
both an affinity purified anti-MAP antiserum and an anti- 
serum specific for mouse MAP2 (Fig.  5).  Third, the cloned 
cDNA probes detected an mRNA species in RNA blot transfer 
experiments of a size consistent with the coding requirement 
of a  protein  of 250,000  D.  On the basis of these data,  we 
conclude that the set of overlapping cDNAs shown in Fig. 4 
are specific for MAP2. 
The expression of MAP2, as determined by immunocyto- 
chemical methods, is a matter of controversy. A number of 
reports describe the detection of MAP2 polypeptides, using 
defined antibodies to MAP2, in non-neuronal cells or tissues 
(26,  3 l,  34).  In contrast, studies by Bernhardt,  Huber, and 
Matus (5) using monoclonal antisera, showed the expression 
of MAP2 exclusively in association with dendritic microtu- 
bules in the adult brain. Our data, in which the mouse MAP2- 
specific  cDNA  probe  was  used  to  detect  MAP2-specific 
mRNA sequences in a  variety of mouse tissues (Fig.  5),  is 
consistent with this conclusion,  as we failed to detect even 
trace quantities of MAP2-specific mRNA from any source 
other than brain. The sensitivity of the hybridization proce- 
dure used in these experiments is such that we would have 
detected MAP2-specific mRNA sequences at a level 103 times 
lower than that present in brain. It appears likely, therefore, 
that the observed immunostaining of non-neuronal cells with 
anti-MAP2 antisera is due to the existence of cross-reacting 
epitopes on non-MAP2 proteins. 
Genomic Southern blots probed with three different and 
largely non-overlapping MAP2-specific cDNA clones (see Fig. 
4)  identified  single  bands  in  digests of mouse  DNA,  even 
under conditions of relatively low stringency (2 x  SSC, 42"C) 
(Fig.  7).  The possibility that MAP2a and MAP2b could be 
transcribed from two genes that do not cross-hybridize at this 
stringency is highly unlikely: the two proteins give very similar 
or  identical  patterns  in  one-dimensional  (21),  two-dimen- 
sional (10), and phosphorylation (2 l) peptide mapping exper- 
iments, and one would expect the extent of protein homology 
implied by these data to be reflected at the DNA level.  For 
example, the genes encoding different members of the rela- 
tively distantly related intermediate filament multigene family 
cross-hybridize at this stringency (16).  In addition, over two- 
thirds  of the  MAP2  coding  region  was  used  in  our cross- 
hybridization studies.  Thus, we conclude that MAP2 is en- 
coded by a  single gene in  mouse. The resolution of MAP2 
into two subcomponents is therefore ascribable either to splic- 
ing  of alternative  exons  from  within  a  single  gene,  or to 
posttranslational modification of MAP2 protein. 
Under reduced stringency conditions,  the MAP2 specific 
eDNA clones detect one or two cross-hybridizing restriction 
fragments in digests of rat, human,  and chicken DNA, but 
not  in  DNA from frog, Drosophila, or sea urchin  (Fig.  8). 
Thus, within the region of MAP2 represented by the series of 
clones  shown  in  Fig.  2,  there  is  considerable  interspecies 
divergence. It is conceivable that the biological function of 
MAP2 is consistent with a significant amount of neutral drift, 
so that the same function is provided by molecules encoded 
by weakly or non-cross-hybridizing genes. Alternatively, the 
observed lack of interspecies conservation may reflect selec- 
tive constraints on small, discrete regions of the molecule or 
regions not encoded by the set of MAP2-specific clones de- 
scribed here. 
Because microtubules are a  feature of virtually all eukar- 
yotic cells, the absence of  detectable MAP2 expression in non- 
neuronal  tissues  implies  that  this  protein  is  certainly  not 
essential to  the  process of microtubule  assembly. Further- 
more, because of the absence of related sequences with de- 
tectable homology to the MAP2-specific clones, the existence 
of  closely related molecules that might serve a similar function 
to  MAP2  in  non-neuronal  cells appears unlikely.  It seems 
probable, therefore, that the biological role of MAP2 is brain- 
specific.  The availability of cloned probes encoding MAP2 
should provide the opportunity for fresh approaches towards 
studying the regulation of MAP2 gene expression as well as 
defining the precise biological function of this protein. 
This work was supported by grants from the National Institutes of 
Health and the Muscular Dystrophy Association. 
Received for publication 13 December 1985, and in revised form 22 
January 1986. 
References 
I.  Amos, L. A.  1977.  Arrangement of high molecular weight associated 
proteins on purified mammalian  brain microtubules. J. Cell Biol. 72:642-654. 
2.  Benton, W.  D., and R.  W.  Davis.  1977.  Screening ~gt recombinant 
clones by hybridization of siogle plaques in situ. Science (Wash. DC). 196:180- 
181. 
3.  Berk, A., and P. Sharp. 1978. Spliced early mRNAs of SV40. Proc. Natl. 
Acad. Sci. USA. 75:1274-1278. 
4.  Bernhardt, R., and A. I. Matus. 1984. Light and electron microscopic 
studies of the distribution of microtubule-asst~ated protein 2 in rat brain. A 
difference  between  dendritic  and  axonal  cytoskeletons. J.  Comp. Neurol. 
226:203-219. 
5.  Bernhardt,  R.,  G.  Huber,  and  A.  Matus.  1985.  Differences in  the 
developmental patterns of three microtubule-associated proteins in  the  rat 
cerebellum. J. Neurosci. 5:977-991. 
6.  Boedtker,  H. 1971. Conformation-independent molecular weight deter- 
mination of RNA by gel electrophoresis.  Biochim. Biophys. Acta. 240:448-453. 
7.  Caceres, A., L. I. Binder, M. R. Payne, P. Bender, L. Rebhun, and O. 
Steward.  1984. Differential  subeellular localization  of tubulin and the micro- 
tubule-associated protein MAP2 in brain tissue as revealed  by immunohisto- 
chemistry with monoelonal hybridoma antibodies. Z Neurosci. 4:394--410. 
8.  Cleveland, D. W., S. Hwo, and M. W. Kirschner. 1977. Purification of 
tau, a  microtubule-associated protein that induces assembly of microtubules 
from purified tubulin. J. Mol. Biol. 116:207-225. 
9.  De Camilli, P., P. E. Miller,  F. Navone, W. E. Theurkauf, and R. B. 
Vallee.  1984. Distribution of microtubule-assoeiated protein 2 in the nervous 
system of the rat studied by immunofluoreseence.  Neuroscience.  I 1:819-846. 
10.  Herrmann, H., J. M. Dalton, and G. Wiche. 1985. Microheterogeneity 
of microtubule associated proteins, MAPI and MAP2, and differential  phos- 
phorylation of individual subcomponents. J. Biol. Chem. 260:5797-5803. 
I I.  Herzog, W., and K. Weber.  1978. Fractionation of brain microtubule 
associated proteins: isolation of two different proteins which stimulate tubulin 
polymerization in vitro. Fur. J. Biochem. 92:1-8. 
12,  Huber, G., and A. Matus. 1984. Differences in the cellular distribution 
of two microtubule associated proteins, MAPl  and MAP2, in rat brain. J. 
Neurosci. 4:151 - 160. 
13.  Izant, J. G., and J. R. Mclntosh. 1980. Microtubule-associated proteins: 
a monoclonal antibody to MAP2 binds to differentiated neurons. Proc. Natl. 
Acad. Sci. USA. 77:4741-4745. 
14.  Kim,  H.,  L.  L  Binder,  and  J.  L.  Rosenbaum.  1979. The  periodic 
association of MAP2 with brain microtubules in vitro. J.  Cell Biol. 80:266- 
276. 
15.  Lewis, S. A., J. M. Balcarek, V. Krek, M. L. Shelanski, and N. J. Cowan. 
1984. Sequence of a eDNA clone encoding mouse glial fibrillary acidic protein: 
structural conservation of intermediate filaments. Proc. Natl. Acad. Sci. USA. 
81:2743-2746. 
16.  Lewis, S. A., and N. J. Cowan. 1985. Genetics, evolution, and expression 
of  the 68,000-mol-wt neurofilament protein: isolation of  a cloned eDNA probe. 
J. Cell Biol. 100:843-850. 
17.  Lewis, S. A., and N. J. Cowan. 1986. Anomalous placement of introns 
in a member of the intermediate filament-multigene family:  an evolutionary 
conundrum. Mol. Cell. Biol. In press. 
The Journal of Cell Biology, Volume 102, 1986  2104 18.  Murphy, D. B., and G. G. Borisy.  1975. Association of high-molecular- 
weight proteins with microtubules and their role in mierotubule assembly in 
vitro. Proc. Natl. Acad Sci.  USA.  72:2696-2700. 
19.  Murphy, D. B., K. A. Johnson, and G. G. Borisy.  1977. Role oftubulin- 
associated proteins in microtubule nucleation and elongation. J. Mol. Biol. 
117:33-52. 
20.  Rigby, P. W. J., M. Dieckmann, C. Rhodes, and P. Berg. 1977. Labelling 
DNA to high specific activity in vitro by nick-translation with DNA polymerase 
I. J. Mol. Biol.  113:237-251. 
21.  ,$chulman, M. 1984. Phosphorylation of microtubule assoeiated proteins 
by a Ca++/calmodulin-dependent protein kinase. J. Cell Biol. 99:11-19. 
22.  Shelanski, M.  L.,  F.  Gaskin, and C.  R.  Cantor.  1973.  Assembly of 
microtubules in the absence of added nucleotide. Proc. Natl. Acad.  Sci.  USA. 
70:765-768. 
23.  Sherline, P., and K. Sehiavone. 1977. lmmunofluorescence  localization 
of proteins of high molecular weight along intracellular microtubules. Science 
(Wash. DC). 198:1038-1040. 
24.  Sloboda,  R. D., S. A. Rudolph, J. U  Rosenbaum, and P. Greengard. 
1975. Cyclic AMP-dependent endogenous phosphorylation of a mierotubule- 
associated protein. Proc. Natl. Acad.  Sci.  USA. 72:177-181. 
25.  Sloboda, R. D., W. L. Dentler, andJ. U Rosenbaum. 1976. Microtubule 
associated proteins and stimulation of tubulin assembly in vitro. Biochemistry. 
15:4497--4505. 
26.  Sloboda,  R. D., and K. Dickersin. 1980. Structure and composition of 
the eytoskeleton of nucleated erythrocytes. I.  The presence of microtubule- 
associated protein 2 in the marginal band. J. Cell Biol. 87:170--179. 
27.  Southern, E.  1975.  Detection of specific  sequences among fragments 
separated by gel electrophoresis. J./t4ol. Biol. 98:503-517. 
28.  Towbin, H., T. Staehlin, and J. Gordon. 1979. Eleetrophoretic  transfer 
of proteins from polyaerylamide gels to nitrocellulose sheets:  procedure and 
some applications. Proc. Natl. Acad. Sci.  USA. 76:4350--4354. 
29.  Valdivia,  M. M., J. Avila, J. Coil, C. Colaco,  and I. V. Sandoval. 1982. 
Quantitation and characterization of the mierotubule associated MAP2 in 
porcine tissues and its isolation from porcine (PKI 5) and human (HeLa) cell 
lines. Biochem. Biophys. Res. Commun. 105:1241-1249. 
30.  Vallee, R. B., G. S. Bloom, and F. C. Luca. 1984. Differential  cellular 
and subcellular distribution of mierotubule-assoeiated proteins. In Molecular 
Biology of the Cytoskeleton. G. G. Borisy, D. ,W. Cleveland, and D. B. Murphy, 
editors. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY. I 11-130. 
31.  Weatherbee, J. A., P. Sherline, R. N. Mascardo, J. G. Izant, R. B. Luttig, 
and R. R. Weihing. 1982. Mierotubule-associated proteins of HeLa cells: heat 
stability of the 200,000 tool wt HeLa MAPs and detection of the presence of 
MAP-2 in HeLa cell extracts and cycled  mierotubules. J.  Cell Biol.  92:155- 
163. 
32.  Weingarten, M. D., A. H. Lockwood, S. -Y. Hwo, and M. W. Kirschner. 
1975. A protein factor essential for microtubule assembly. Proc. Natl Acad. 
Sci.  USA. 72:1858-1862. 
33.  Withe, G., E. Briones,  H. Hirt, U. Artlieb,  and H. Denk. 1983. Differ- 
ential distribution of microtubule-associated proteins MAPI  and MAP2 in 
neurons of rat brain, and association of MAPI with mierotubules of neuro- 
blastoma cells (clone N~A). EMBO (Eur. Mol. Biol. Organ.) J. 2:1915-1920. 
34.  Withe, G., E. Briones, C. Koszka, U. Artlieb,  and R. Koepler.  1984. 
Widespread occurrence of polypeptides related  to neurotubule-associated pro- 
teins (MAPI and MAP2) in non-neuronal cells and tissues. EMBO (Fur. Mol. 
Biol. Organ.)J. 3:991-998. 
35.  Young, R. A., and R. W. Davis. 1983. Efficient  isolation of genes by 
using antibody probes. Proc. Natl. Acad.  Sci.  USA. 80:1194-1198. 
Lewis et al. Brain-specific Expression of  MAP2  2105 